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Background: Androgenetic alopecia (AGA) is a common cause of hair loss in men. It is associated with the
risk of cardiovascular disease and metabolic syndrome. Additionally, it is suggested that premature AGA
could be considered equivalent to that of polycystic ovary syndrome in women.
Objective: The aim of this study was to examine the relation between AGA and the quality of semen.
Methods: The semen specimens were collected from 203 young adult men included in the study. AGA
was classiﬁed according to the Hamilton baldness scale, modiﬁed by Norwood. All participants were
classiﬁed into two categories: normal to mild AGA (equivalent to Norwood types IeII) as Group I and
moderate to severe AGA (equivalent to Norwood types IIIeVII) as Group II to assess the difference in the
quality of sperms between the two groups.
Results: There were no statistically signiﬁcant differences in the men's age and body mass index scores
among the groups. For both Groups I and II, the history of smoking and varicocele was not statistically
different (p ¼ 0.62 and p ¼ 0.11, respectively). All parameters of sperm including volume, density,
motility, and morphology were signiﬁcantly lower in participants with moderate to severe AGA than
those with normal to mild AGA (p < 0.01, p < 0.01, p < 0.01, and p < 0.01, respectively).
Conclusion: This study showed that young adult men with moderate to severe AGA have poor quality of
semen compared with those who have normal to mild AGA.
Copyright © 2015, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Infertility is reported in 10e15% of couples attempting to conceive
during their reproductive life span. A male factor is identiﬁed in
40e60% of these couples and is the sole etiology in 20% of all
couples seeking assistance for infertility.1 In a considerable number
of men with abnormal semen characteristics, the etiology is un-
explained and may involve unknown environmental factors.2 One
of the main laboratory tests for evaluation of infertility is semen
analysis (SA).
Androgenetic alopecia (AGA) is a common cause of hair loss in
men. Numerous studies in recent decades have associated maley have no ﬁnancial or non-
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.AGA with the risk of cardiovascular disease and metabolic syn-
drome (MS).3e7 In addition, some studies have inferred that pre-
mature baldness prior to the age of 30 in men could be considered
equivalent to that of polycystic ovary syndrome (PCOS) in women.8
Narad et al9 and Arias-Santiago et al10 reported decreased levels of
sex hormone-binding globulin (SHBG) inmenwith premature AGA.
We expect that if premature AGA is associated with these systemic
diseases and changes in the hormone proﬁle, it might also be
related to the quality of semen. Hence, the aim of this study was to
investigate the relation between AGA and the quality of sperm.
Materials and methods
Participants
The study population consisted of healthy young adult males
among the couples visiting the infertility clinic between October
2012 and December 2013. Participants who did not provide a
semen sample or those with a history of vasectomy, cryptorchism,evier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Table 1 Demographic characteristics of Group I (normalemild AGA) and Group II
(moderateesevere AGA).
Group I (n ¼ 115) Group II (n ¼ 85) p
Mean Mean
Age 31.8 ± 5.6 31.9 ± 5.9 >0.05
BMI 26.0 ± 3.3 25.8 ± 3.1 >0.05
Smoking þ 46/ 36.5% 30/ 40% >0.05
 80/ 63.5% 45/ 60% >0.05
AGA ¼ androgenetic alopecia; BMI ¼ body mass index.
Figure 1 Participants with moderateesevere AGA (Hamilton IIIeVII) having signiﬁ-
cantly lower sperm count than normalemild AGA (Hamilton IeII). AGA ¼ androgenetic
alopecia.
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and endocrine hypogonadism were excluded from the study. The
cigarette smoking status and body mass index (BMI) values of
participants were recorded. Those with a history of medications
especially of ﬁnasteride and dutasteride were excluded from the
study. A total of 203 men were included in the study, and semen
specimens were collected from these individuals.
Assessment of AGA
AGA was classiﬁed according to the Hamilton baldness scale, as
modiﬁed by Norwood.11 All participants were classiﬁed into two
categoriesdnormal tomild AGA (equivalent to Norwood types IeII)
as Group I and moderate to severe AGA (equivalent to Norwood
types IIIeVII) as Group IIdto assess the difference in the quality of
sperm among the two groups.
Approval by the institutional review boardwas not necessary for
this study in our clinic because all the analyses described in this
study were part of the routine infertility investigation; in addition,
the men were only evaluated for their AGA status with physical
examination during the interview with the couples. However,
informed consent was obtained from each of the patients with
respect to these clinical examinations in this study.
Semen samples were collected by ejaculation into special sterile
plastic containers after 2 to 7 days of sexual abstinence. SA was
performed within 2 hours of collection of the semen specimens.
SA
SA consisted of determination of sample volume, sperm density,
progressive motility, and morphology. Standard clinical SA was
performed according to World Health Organization criteria.12
Ejaculate volumes were estimated by the weight of the specimen,
assuming a semen density of 1.0 g/mL. Sperm concentration was
evaluated using a hemocytometer (Improved Neubauer; Hauser
Scientiﬁc, Inc., Horsham, PA, USA). Motility was analyzed using the
World Health Organization 1999 criteria and classiﬁed as both
progressive (A þ B) and total (A þ B þ C). Sperm abnormal forms
were examined according to Kruger's strict criteria.13
Statistical analysis
The primary outcomes of interest in this study were semen volume,
sperm concentration, motility percentage, and normal morphology
percentage. Covariates considered in the analysis were age, ciga-
rette use, and BMI.
Average, standard deviation, median, lowest, highest, rate and
frequency values were used for the descriptive statistics of the data.
Distribution of the variables was analyzed using the Kolmogor-
oveSmirnov test. Quantitative data were analyzed using the Man-
neWhitney U test. Qualitative data were analyzed using the chi-
square test; when conditions for the chi-square test were not
satisﬁed, Fischer's exact test was used. A value of p < 0.05 was
considered statistically signiﬁcant. All statistical analyses were
performed using SPSS 22.0 for Windows (SPSS Inc., Chicago, IL,
USA).
Results
Table 1 shows some of the demographic characteristics of the
participants. No statistically signiﬁcant differencewas found for the
men's age and BMI scores within the groups. In Groups I and II,
cigarette smoking and varicocele history were not statistically
signiﬁcant (p < 0.62 and p < 0.11, respectively).Figure 1 shows that the participants with moderate to severe
AGA had signiﬁcantly lower sperm counts than those in the normal
to mild AGA group (p < 0.0001). All sperm parameters were
signiﬁcantly worse in participants with moderate to severe AGA
compared with those of the normal to mild AGA group. Sperm
volume, density, motility, and morphology were signiﬁcantly lower
or poor in participants with moderate to severe AGA than those in
normal to mild AGA group (Table 2) (p ¼ 0.002, p < 0.01, p < 0.01,
and p < 0.01, respectively).
Figures 2 and 3 illustrate the signiﬁcantly worse sperm motility
and morphology in moderate to severe AGA group (p < 0.01 and
p < 0.01, respectively).Discussion
Because all of the included participants were from infertile couples,
this appears to be a limitation of the study at ﬁrst glance. However,
as the control group (men without AGA or mild AGA) of the study
also comprises participants from infertile couples of the same
population, we believe that this fact would not have inﬂuenced the
results of the study. Moreover, as the severity of AGA increases with
advancing age, this does not have an inﬂuence on the results,
because both groups in this study share similar mean ages.
This study showed that young adult men with moderate to se-
vere AGA, according to the Hamilton baldness scale, have poor
semen quality compared with those with normal hair status. Pre-
vious studies on semen quality showed that decreased levels of
Table 2 Sperm parameters of Group I (normalemild AGA) and Group II (moderateesevere AGA).
Group I (n ¼ 115) Group II (n ¼ 88) p
Mean ± SD Minemax Mean ± SD Minemax
Semen volume (mL) 2.8 ± 1.2 0.5e7.5 2.3 ± 1.5 0.0e8.0 0.002
Sperm count (06/ml) 59.1 ± 62.3 0e470 36.5 ± 56.8 0e275 <0.01
Rapid progressively motile sperm (%) 40.5 ± 16.6 0e81 23.2 ± 19.3 0e67 <0.01
Slow progressively motile sperm (%) 18.5 ± 11.4 0e57 12.5 ± 10.4 0e40 <0.01
Morphologically normal sperm (%) 8.4 ± 6.7 0e54 4.1 ± 4.2 0e21 <0.01
AGA ¼ androgenetic alopecia; SD ¼ standard deviation.
Figure 2 Participants with moderateesevere AGA (Hamilton IIIeVII) having signiﬁ-
cantly lower sperm motility than normalemild AGA (Hamilton IeII).
AGA ¼ androgenetic alopecia.
Figure 3 Participants with moderateesevere AGA (Hamilton IIIeVII) having signiﬁ-
cantly lower sperm morphology than normalemild AGA (Hamilton IeII).
AGA ¼ androgenetic alopecia.
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glycoprotein that binds to the sex hormones, androgen and estro-
gen. SHBG is produced mostly by the liver and released into the
bloodstream. SHBG levels are decreased by androgens, adminis-
tration of anabolic steroids, PCOS, hypothyroidism, obesity, Cush-
ing's syndrome, and hirsutism. Low SHBG levels increase the
probability of type 2 diabetes.16 In addition, Narad et al9 reported
decreased levels of SHBG in cases with AGA. Arias-Santiago et al10
showed an association between early onset of AGA, hyperglyce-
mia/diabetes, and low levels of SHBG, and suggested that low levels
of SHBG could be amarker of insulin resistance and hyperglycemia/
diabetes in patients with AGA.10 Jensen et al14 reported that alcohol
intake and poor semen quality are associated with reduction in
levels of SHBG. Moreover, Duskova et al17 suggested premature
alopecia as one of the signs of male phenotype of PCOS. Patients
with PCOS have lower SHBG, lower follicle-stimulating hormone,
and elevated free androgen index. It has been shown that over-
weight men have signiﬁcantly lower SHBG levels, and their semen
parameters are signiﬁcantly worse.15 Moreover, Safarinejad et al18
reported that baseline SHBG levels tended to be lower in infertile
men (21.1 ± 7.2 nmol/L) compared with normal fertile men
(24.7 ± 7.9 nmol/L). All these systemic hormonal changes may also
be true for the patients with AGA, and these changesmay also affect
spermatogenesis. Therefore, these assumptions may explain our
ﬁndings on all the sperm parameters including total sperm volume,
motility, and morphology.
Similar to these ﬁndings, AGA was found to be associated with
MS,3 and several studies reported thatMS affects sperm parameters
adversely.19,20 Chakrabarty et al21 demonstrated that AGA is asso-
ciated with MS. Bakry et al22 reported a statistically signiﬁcant
association between AGA and MS (p ¼ 0.002). Meanwhile, Leise-
gang et al23 reported that patients with MS had signiﬁcant re-
ductions in sperm concentration, total sperm count, and total
motility.
It is hypothesized that a systemic proinﬂammatory state with
oxidative stress is associated with MS, AGA, and worsening of the
sperm parameters. Rosety et al19 reported that sperm concentra-
tion and the percentage of sperms with normal motility and
morphology were signiﬁcantly lower in adults with MS, when
compared with their healthy normal weight counterparts, and they
attributed this to increased seminal oxidative damage. Omu24
concluded that MS and low SHBG levels adversely affect semen
quality. Lotti et al25 reported that MS is associated with hypo-
gonadism, poor sperm morphology, and testis ultrasound in-
homogeneity. Oxidative stress at the level of testicular
microenvironment may result in decreased spermatogenesis and
sperm damage.24 Therefore, elucidation of the complex interaction
between MS and reproductive functions will have clinical impli-
cations in the therapeutic approach of both the entities, and this
may also beneﬁt the treatment of AGA.
In conclusion, this study demonstrated that the studied semen
parameters were signiﬁcantly worse in men with moderate to se-
vere AGA than in men with normal to mild AGA (p < 0.01). This
E.S. Güng€or et al. / Dermatologica Sinica 34 (2016) 10e13 13study showed that menwith AGA had poor semen quality. Patients
with AGA have certain hormonal and metabolic changes that affect
all systems, and these changes might also have some bad effect on
spermiogram parameters.References
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